000 | 01729 a2200529 4500 | ||
---|---|---|---|
005 | 20250515103623.0 | ||
264 | 0 | _c20080513 | |
008 | 200805s 0 0 eng d | ||
022 | _a1468-3288 | ||
024 | 7 |
_a10.1136/gut.2006.103200 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAndre, E | |
245 | 0 | 0 |
_aExpression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder. _h[electronic resource] |
260 |
_bGut _cMay 2008 |
||
300 |
_a628-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAtropine _xpharmacology |
650 | 0 | 4 | _aBradykinin B1 Receptor Antagonists |
650 | 0 | 4 | _aBradykinin B2 Receptor Antagonists |
650 | 0 | 4 |
_aCholecystitis _xdrug therapy |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGallbladder _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscarinic Antagonists _xpharmacology |
650 | 0 | 4 |
_aReceptor, Bradykinin B1 _xmetabolism |
650 | 0 | 4 |
_aReceptor, Bradykinin B2 _xmetabolism |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
700 | 1 | _aGazzieri, D | |
700 | 1 | _aBardella, E | |
700 | 1 | _aFerreira, J | |
700 | 1 | _aMori, M A | |
700 | 1 | _aSaul, V V | |
700 | 1 | _aBader, M | |
700 | 1 | _aCalixto, J B | |
700 | 1 | _aDe Giorgio, R | |
700 | 1 | _aCorinaldesi, R | |
700 | 1 | _aGeppetti, P | |
700 | 1 | _aTrevisani, M | |
773 | 0 |
_tGut _gvol. 57 _gno. 5 _gp. 628-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2006.103200 _zAvailable from publisher's website |
999 |
_c17692435 _d17692435 |